MMR-deficient tumors markedly increase inflammatory gene expression in tumor-infiltrating macrophages and fibroblasts, are enriched for tumor-specific CD8+ T cells, and have increased tumor cell expression of IFN-stimulated genes and chemokines (Pelka et al, 2021). The gene discussed is CD8A; the disease is neoplasm.